Emicizumab (Anti-F9 / Factor IX)
Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2502 |
Sku # | A2502-1mg |
Pricing | 1mg, $2670.00 |